A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis

Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists for monitoring clinically silent MS disease activity and, where ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Michael, Wang, Dongang, Beadnall, Heidi, Bischof, Antje, Brunacci, David, Butzkueven, Helmut, Brown, J. William L., Cabezas, Mariano, Das, Tilak, Dugal, Tej, Guilfoyle, Daniel, Klistorner, Alexander, Krieger, Stephen, Kyle, Kain, Ly, Linda, Masters, Lynette, Shieh, Andy, Tang, Zihao, van der Walt, Anneke, Ward, Kayla, Wiendl, Heinz, Zhan, Geng, Zivadinov, Robert, Barnett, Yael, Wang, Chenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587188/
https://www.ncbi.nlm.nih.gov/pubmed/37857813
http://dx.doi.org/10.1038/s41746-023-00940-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587188/
https://www.ncbi.nlm.nih.gov/pubmed/37857813
http://dx.doi.org/10.1038/s41746-023-00940-6

Ejemplares similares